Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Surveillance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05667064
What this trial is testing

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Who this might be right for
Unresectable Hepatocellular Carcinoma
AstraZeneca 1,200
Not applicableStudy completedNCT03232593
What this trial is testing

Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

Who this might be right for
Urothelial CarcinomaCarcinoma, Non-Small Cell LungSmall Cell Lung Carcinoma+2 more
Hoffmann-La Roche 1,758
Not applicableStudy completedNCT02269995
What this trial is testing

Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eisai Co., Ltd. 300
Not applicableEnded earlyNCT05342350
What this trial is testing

International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy

Who this might be right for
Liver CancerLiver CirrhosisHepatocellular Carcinoma+1 more
Johns Hopkins University 360
Not applicableUnknownNCT05429190
What this trial is testing

Validation of SMS Protocol for HCC Screening in High-risk Patients

Who this might be right for
Hepatocellular Carcinoma
Erasmus Medical Center 470
Not applicableLooking for participantsNCT06778317
What this trial is testing

MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)CirrhosisRisk Prediction for Liver Cancer+1 more
Central Hospital, Nancy, France 400
Not applicableStudy completedNCT01411436
What this trial is testing

Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan

Who this might be right for
Carcinoma, Hepatocellular
Bayer 1,637
Not applicableLooking for participantsNCT06537193
What this trial is testing

Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment

Who this might be right for
Hepatocellular Carcinoma
Asan Medical Center 455
Not applicableStudy completedNCT03776123
What this trial is testing

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaDifferentiated Thyroid Carcinoma
Ipsen 347
Not applicableStudy completedNCT03756051
What this trial is testing

Harms of Hepatocellular Carcinoma Surveillance

Who this might be right for
Carcinoma, Hepatocellular
University of Texas Southwestern Medical Center 2,871
Not applicableUnknownNCT06134973
What this trial is testing

A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC.

Who this might be right for
Hepatocellular Carcinoma
Tianjin Third Central Hospital 1,000
Not applicableNot Yet RecruitingNCT07010588
What this trial is testing

Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk

Who this might be right for
Hepatocellular Carcinoma (HCC)Magnetic Resonance Imaging (MRI)Randomized Controlled Trial
Peking University People's Hospital 1,389
Not applicableLooking for participantsNCT05502198
What this trial is testing

Relevance of Sarcopenia in Advanced Liver Disease

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaSarcopenia+1 more
Linkoeping University 150
Not applicableUnknownNCT01277653
What this trial is testing

Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Yonsei University 1,000
Not applicableLooking for participantsNCT06861114
What this trial is testing

Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhujiang Hospital 38
Not applicableLooking for participantsNCT05971108
What this trial is testing

Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC

Who this might be right for
Liver CirrhosisHepatocellular Carcinoma
Manchester University NHS Foundation Trust 600
Not applicableUnknownNCT02817685
What this trial is testing

Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 7,660
Not applicableActive Not RecruitingNCT04965259
What this trial is testing

Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)

Who this might be right for
Liver Diseases
National Cancer Centre, Singapore 2,002
Not applicableLooking for participantsNCT06184152
What this trial is testing

CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

Who this might be right for
HCCHepatocellular Carcinoma
University of Texas Southwestern Medical Center 600
Not applicableNot Yet RecruitingNCT07675187
What this trial is testing

HCC Risk and Monitoring in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes (T2DM)Hepatocellular Carcinoma (HCC)
National Taiwan University Hospital 2,400
Next Page